Article info
PDFCorrespondence response
Response to: ‘Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease’ by Orlando et al
- Correspondence to Dr D Elewaut, Department of Rheumatology, Ghent University Hospital, Ghent 9000, Belgium; dirk.elewaut{at}ugent.be
Citation
Response to: ‘Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease’ by Orlando et al
Publication history
- Received January 11, 2017
- Accepted January 16, 2017
- First published February 9, 2017.
Online issue publication
October 31, 2019
Article Versions
- Previous version (31 October 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/